Theravance Biopharma (TBPH) Net Margin (2013 - 2026)
Theravance Biopharma (TBPH) recorded Net Margin of -28.45% in Q2 2026, down 237.78 percentage points from 209.33% a year earlier and down 0.58 percentage points from the prior quarter.
Powered by 
Analysis
Theravance Biopharma (TBPH) Net Margin (2013 - 2026) Analysis & Trends
On a TTM basis, Theravance Biopharma's Net Margin came in at 51.58% as of Jun 30, 2026, up 34.71 percentage points year-over-year; for FY2025, it was 98.54%, up 186.17 percentage points from FY2024.
- Annual Net Margin has a five-year change of +485.44 percentage points (FY2020 to FY2025).
- Across earlier years, Net Margin came in at -87.63% in FY2024 (+8.48 pp), -96.11% in FY2023 (-1794.65 pp), 1698.54% in FY2022 (+2059.09 pp) and -360.55% in FY2021 (+26.35 pp).
- The Q2 2026 figure is the lowest quarterly Net Margin since Q1 2025.
- On a year-over-year basis, Net Margin rose in four of the last eight quarters, with an average year-over-year change of +49.57 percentage points.
- Peak year-over-year performance for Net Margin in the last five years was a gain of 7629.51 percentage points in Q3 2022, against a drop of 7418.94 percentage points in Q3 2023 at the low end.
- Per Business Quant, the preceding three quarters came in at -27.87% (Q1 2026), 132.98% (Q4 2025) and 18.08% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 30.88% |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 21.86% |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 21.27% |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | -8.04% |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | 22.65% |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 16.30% |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 23.62% |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | -134.51% |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | -1.65% |
| 10 | Theravance Biopharma | 883.70 Mn | -543.66 Mn | - | -28.45% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -28.45% |
| Mar 31, 2026 | -27.87% |
| Dec 31, 2025 | 132.98% |
| Sep 30, 2025 | 18.08% |
| Jun 30, 2025 | 209.33% |
| Mar 31, 2025 | -88.24% |
| Dec 31, 2024 | -82.79% |
| Sep 30, 2024 | -75.28% |
| Jun 30, 2024 | -115.94% |
| Mar 31, 2024 | -80.42% |
| Dec 31, 2023 | -48.45% |
| Sep 30, 2023 | -57.03% |
| Jun 30, 2023 | -113.79% |
| Mar 31, 2023 | -212.04% |
| Dec 31, 2022 | -70.74% |
| Sep 30, 2022 | 7,361.91% |
| Jun 30, 2022 | -74.13% |
| Mar 31, 2022 | -196.62% |
| Dec 31, 2021 | -214.33% |
| Sep 30, 2021 | -267.61% |
API Access
Theravance Biopharma Net Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-margin&ticker=TBPH&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-margin", "ticker": "TBPH", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-margin&ticker=TBPH&period=max&api_key=YOUR_API_KEY");
const data = await res.json();